AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
OXAZEPAM
22 registrations across 3 African markets— 15 active
Markets with OXAZEPAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MEDOPAM 10 | 🇿🇦South Africa | Alliance Pharma (Pty) Ltd | suspended | Jul 2025 |
| MEDOPAM 15 | 🇿🇦South Africa | Alliance Pharma (Pty) Ltd | suspended | Jul 2025 |
| MEDOPAM 30 | 🇿🇦South Africa | Alliance Pharma (Pty) Ltd | suspended | Jul 2025 |
| ADCO-OXAZEPAM TABLETS 30 mg* | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jul 2025 |
| NORIPAM 30 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2022 |
| SERESTA Comprimé / 10 MG | 🇹🇳Tunisia | NEURAXPHARM FRANCE | expired | Jun 2020 |
| SERESTA Comprimé sécable / 50 MG | 🇹🇳Tunisia | NEURAXPHARM FRANCE | expired | Jun 2020 |
| ADCO-OXAZEPAM TABLETS 15 mg* | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| SEREPAX 10 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| SEREPAX 15 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| SEREPAX FORTE | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| PURATA - 15 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| PURATA - 30 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| NORIPAM 15 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| NORIPAM 10 mg | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| PURATA - 10 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ADCO-OXAZEPAM TABLETS 10 mg* | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| ZIMTEC 15 | 🇿🇦South Africa | Arya Pharma (Pty) Ltd | active | Jan 1900 |
| ZIMTEC 30 | 🇿🇦South Africa | Arya Pharma (Pty) Ltd | active | Jan 1900 |
| SERESTA | 🇸🇳Senegal | — | active | — |
| SERESTA comprimé / 50 mg | 🇸🇳Senegal | NEURAXPHARM | active | — |
| SERESTA comprimé / 50 mg | 🇸🇳Senegal | BIODIM | active | — |
OXAZEPAM in Africa — Regulatory Overview
OXAZEPAM is registered across 3 African markets with 22 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 22 registrations, 15 (68%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.